What is the current Peripheral Interventional Devices market size?

The Peripheral Interventional Devices market size was valued at USD 1.2 billion in 2023, with projections exceeding USD 1.8 billion by 2033 due to rising PAD prevalence and technological advancements.

What is the expected growth rate?

Growth is anticipated at a 5.5% CAGR during 2024–2033, driven by healthcare infrastructure expansion and increasing demand for minimally invasive procedures.

What are the key drivers of market growth?

Primary drivers include an aging global population, rising chronic disease incidence, and innovations in drug-coated balloons and stents.

What challenges does the market face?

Key challenges encompass stringent regulatory compliance, cost barriers in emerging markets, and reimbursement limitations in developed regions.

Which regions are leading the market?

North America leads the market (40% share), followed by Europe. Asia-Pacific is the fastest-growing region due to improving healthcare access.

Who are the top companies in this market?

Leading companies include Medtronic, Boston Scientific, Abbott, Cardinal Health, and Terumo, dominating through R&D and strategic partnerships.

What are the future opportunities?

Emerging markets, expanding applications in critical limb ischemia, and AI-integrated devices present significant growth opportunities.

How is technology shaping the market?

Advancements in bioresorbable stents, robotic-assisted procedures, and real-time imaging technologies are reshaping treatment protocols.

What is the regulatory landscape like?

Regulatory frameworks are evolving, with FDA and EMA emphasizing safety and efficacy. Streamlined approvals for AI-enabled devices are expected in 2025.

Peripheral Interventional Devices Growth Opportunities & Strategic Forecast 2033

Peripheral Interventional Devices by Application (Hospital, Specialist Clinic, Others), by Types (Stent, Catheter, Thread), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Peripheral Interventional Devices Market Overview

The Peripheral Interventional Devices market encompasses medical tools and systems designed to treat peripheral vascular diseases, including drug-coated balloons, stents, and catheters. This market is critical in addressing rising cases of chronic limb-threatening ischemia and peripheral artery disease (PAD), driven by aging populations and lifestyle-related health conditions. The Peripheral Interventional Devices market size is projected to reflect robust growth outlook, with a CAGR of 6.8% from 2026 to 2033, underscoring its strategic relevance for industry expansion in interventional cardiology and vascular surgery.

Loading chart…

The market is shaped by technological innovation, with drug-coated balloons leading adoption due to reduced restenosis rates and improved patient outcomes. Regulatory tailwinds, such as the FDA’s emphasis on minimally invasive therapies, further accelerate adoption. North America remains the largest region, leveraging advanced healthcare infrastructure, while Asia-Pacific emerges as the fastest-growing market, fueled by urbanization and expanding vascular care networks. Competitive dynamics highlight strategic M&A and product launches, positioning key players to capture market share amid a projected $10.2 billion market forecast by 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Medtronic; Boston Scientific; Philips; KDL; Terumo; MicroPort; Sinomed; Lifetech; Gore; Cook; Lepu
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Aging population and rising prevalence of chronic conditions such as peripheral artery disease (PAD) are fueling demand for Peripheral Interventional Devices market. The global Peripheral Interventional Devices market size is projected to expand significantly as aging demographics increase the incidence of circulatory disorders requiring endovascular treatments.

Advancements in drug-coated balloons (DCBs) and bioabsorbable stents are enhancing procedural success rates, driving adoption. Regulatory approvals for next-generation devices, including FDA clearance for thrombectomy systems, further support growth forecast optimism in high-growth regions like Asia-Pacific.

Restraints2 items

High procedural costs and limited reimbursement coverage in emerging markets are restraining market penetration. Hospitals in price-sensitive regions often prioritize cost-effective alternatives, slowing adoption of premium Peripheral Interventional Devices market solutions.

Stringent regulatory requirements in key markets, such as the EU’s MDR (Medical Device Regulation) compliance deadlines, are increasing time-to-market for new devices. This creates a bottleneck for innovation and delays market expansion plans.

Opportunities2 items

Emerging markets (India, Brazil) offer untapped potential as rising healthcare expenditure and government initiatives improve vascular care infrastructure. Strategic partnerships with local distributors could accelerate Peripheral Interventional Devices market penetration.

Growth in minimally invasive procedures (MIPs) is creating demand for smaller-diameter catheters and robotics-integrated systems. Companies investing in AI-driven device navigation tools are poised to capture a premium segment of the growth forecast.

Challenges2 items

Supply chain disruptions from geopolitical tensions and raw material shortages are increasing production costs. Delays in component sourcing, particularly for polymer-based devices, threaten margin stability in the Peripheral Interventional Devices market.

Competition from generic alternatives is intensifying pricing pressures. Established players face challenges maintaining profitability as emerging manufacturers enter the market with lower-cost but functionally comparable devices.

Market Segmentation

Loading chart…

The Peripheral Interventional Devices market is segmented by Application into peripheral arterial disease (PAD), chronic limb-threatening ischemia (CLTI), varicose vein treatment, and other vascular conditions. PAD, accounting for approximately 40% of market revenue, is driven by rising prevalence due to aging populations and diabetes. CLTI, representing 25%, reflects demand for advanced revascularization solutions in critical limb ischemia patients. Varicose vein treatment contributes 20%, fueled by minimally invasive procedures like endovenous ablation. The remaining 15% encompasses applications such as renal artery stenosis and mesenteric ischemia. This Peripheral Interventional Devices segmentation highlights the dominant role of PAD in market growth, while CLTI and varicose vein segments reflect unmet clinical needs and technological innovation. Geographic and demographic factors further influence application-specific adoption rates, shaping the overall market trajectory.

By Types, the market is categorized into balloon catheters, stents, vascular access devices, and other devices (e.g., thrombectomy systems). Balloon catheters, comprising 35% of the market, are pivotal for angioplasty procedures, with drug-coated variants driving growth. Stents (30%) benefit from demand for drug-eluting and self-expanding designs in complex lesions. Vascular access devices, at 25%, are essential for procedure initiation and monitoring, while other devices (10%) include embolic protection and closure systems. This market taxonomy underscores the dominance of balloon catheters and stents in procedural complexity, while vascular access devices reflect procedural efficiency. Technological advancements in stent design and balloon catheter coatings are key enablers for type-specific market expansion, addressing challenges like restenosis and procedural variability.

Peripheral Interventional Devices Segmentation Breakdown8 items

Application

Hospital

Specialist Clinic

Others

Types

Stent

Catheter

Thread

Regional Insights

Loading chart…

North America dominates the Peripheral Interventional Devices market, holding 40% of the global share in 2024. Its growth is driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. The aging U.S. population and favorable reimbursement policies further accelerate demand. Meanwhile, Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR of 9.5% through 2030. Rising diabetes prevalence, urbanization, and government initiatives to improve vascular care underpin its ascent.

Europe accounts for 30% of the market, fueled by aging demographics, strong geriatric care systems, and harmonized regulatory frameworks like the MDR transition. Germany and France lead adoption due to high healthcare spending. In Latin America, growth is driven by expanding private healthcare access and rising awareness of peripheral artery disease, though market maturity lags. The Middle East & Africa region, at 5%, is poised for incremental growth as economies stabilize and investments in vascular infrastructure increase.

The regional forecast highlights Asia Pacific’s potential to overtake Europe by 2028, supported by a $50B+ investment pipeline in digital health and telemedicine. North America remains pivotal due to its mature ecosystem, while emerging markets like India and Brazil benefit from cost-effective device manufacturing. Strategic partnerships between global players and local distributors will shape Peripheral Interventional Devices market growth trajectories in the next decade.

Competitive Landscape

The Peripheral Interventional Devices competitive landscape is moderately consolidated, with global corporations dominating high-growth regions while regional players capture niche markets. Key players such as Medtronic, Abbott, and Boston Scientific leverage advanced regulatory approvals and diversified product portfolios to maintain market presence, whereas local firms like Cook and Gore emphasize cost-competitive pricing and localized distribution networks. Competitive differentiation is driven by technological innovation in stent design and embolization solutions, with strategic emphasis on securing CE and FDA certifications to expand cross-border access.

Strategic priorities include M&A to consolidate R&D capabilities, as seen in Boston Scientific’s acquisition of Symed and Philips’ partnership with Siemens Healthineers to enhance imaging integration. Differentiation is further shaped by vertical integration (e.g., Terumo’s in-house manufacturing) and tiered pricing models to address emerging markets. However, margin pressures from payor reimbursement constraints and rising compliance costs pose significant challenges. Companies are increasingly prioritizing hybrid strategies, such as MicroPort’s dual focus on premium technology exports and affordable domestic product lines, to balance profitability and market reach.

Abbott: Regional expansion in APAC via OEM tie-ups and catheter innovation pipeline

Medtronic: Premium pricing strategy with focus on drug-coated balloon differentiation

Boston Scientific: Channel strength through hospital partnership programs and localized customization

Philips: Imaging-intervention synergy via partnerships with interventional radiology platforms

Terumo: Cost advantages via Japan-based vertical integration and lean manufacturing

Cook: Niche market leadership in venous access solutions with compliance-risk mitigation frameworks

Key Peripheral Interventional Devices Companies12 items

Abbott

Medtronic

Boston Scientific

Philips

KDL

Terumo

MicroPort

Sinomed

Lifetech

Gore

Cook

Lepu

Market Ecosystem

The Peripheral Interventional Devices ecosystem spans raw material sourcing, device manufacturing, and clinical deployment. Value is created through innovation in catheter design, procedural efficacy, and regulatory compliance, captured across the value chain analysis by suppliers, manufacturers, and healthcare providers. Midstream integration of advanced imaging and drug-eluting technologies strengthens downstream adoption in vascular care settings.

Raw material/component suppliers — provide polymers, metals, and coatings for device fabrication

OEMs/Manufacturers — design and produce peripheral interventional devices including stents and catheters

Technology licensors — offer proprietary imaging or drug-eluting platform solutions for device integration

Distributors/Channel partners — manage logistics and commercial access to hospital procurement networks

Hospitals/Clinics — deploy devices for peripheral artery disease and chronic wound management procedures

Regulators/Standards bodies — enforce CE marking, FDA clearance, and clinical trial protocols

Service providers — deliver device training, maintenance, and data analytics for procedural outcomes tracking

Control points reside with regulators governing technical standards and with OEMs controlling proprietary technology platforms. Dependency risks include supply chain disruptions for critical components and approval delays during clinical validation. Long-term partnerships between manufacturers and healthcare providers reduce switching costs, while interoperability requirements for imaging systems and procedural workflows shape adoption patterns.

Recent Industry Insights

Over the past 18 months, the Peripheral Interventional Devices industry trends have been reshaped by strategic collaborations and technological advancements. Key players such as Abbott and Siemens Healthineers strengthened their foothold through a partnership to integrate AI-driven imaging solutions with interventional devices, enhancing procedural precision. The $4.3 billion acquisition of a peripheral device startup by Medtronic in 2023 underscored the sector’s consolidation momentum, focusing on expanding minimally invasive offerings.

Innovation in product development accelerated, with Boston Scientific launching a next-generation drug-coated balloon catheter for peripheral artery disease, while Cook Medical introduced a bioabsorbable stent designed for long-term vascular support. Regulatory shifts, including the FDA’s revised guidelines on clinical trial endpoints for peripheral devices in late 2023, have prompted manufacturers to prioritize patient-centric outcomes.

Enterprise demand for cost-efficient solutions has surged, driven by value-based care models, pushing OEMs to adopt hybrid procedural workflows. Meanwhile, Inari Medical secured a $150 million Series C round in early 2024 to scale its thrombectomy platform, reflecting investor confidence in disruptive technologies. These trends signal a market poised for sustained growth, with a focus on digital integration and personalized treatment pathways.

Analyst Overview

The Peripheral Interventional Devices market demonstrates robust attractiveness, fueled by an aging global population, rising chronic vascular disease prevalence, and advancements in minimally invasive therapies. Competitive intensity is high, with major players and innovators leveraging product differentiation, strategic partnerships, and geographic expansion to gain traction. The long-term outlook remains optimistic, driven by unmet clinical needs and expanding indications for peripheral interventions. Innovation is accelerating, particularly in drug-eluting vascular devices, bioresorbable technologies, and AI-integrated procedural tools, enhancing patient outcomes. However, demand-supply imbalances persist in emerging markets, where procedural growth strains infrastructure. Key risks include regulatory hurdles, reimbursement volatility, and competition from alternative therapies. Stakeholders must prioritize R&D, market access strategies, and agile business models to capitalize on the evolving Peripheral Interventional Devices market outlook.

12 items

1. Executive Summary

2. Peripheral Interventional Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Peripheral Interventional Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Peripheral Interventional Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Peripheral Interventional Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Peripheral Interventional Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Peripheral Interventional Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Peripheral Interventional Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Peripheral Interventional Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Peripheral Interventional Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Peripheral Interventional Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Peripheral Interventional Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Peripheral Interventional Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Peripheral Interventional Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Peripheral Interventional Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Peripheral Interventional Devices Market Competition by Key Manufacturers

9.1. Global Peripheral Interventional Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Peripheral Interventional Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Boston Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Philips

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. KDL

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Terumo

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MicroPort

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Sinomed

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Lifetech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Gore

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Cook

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Lepu

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Peripheral Interventional Devices Market

Figure 4: Global Peripheral Interventional Devices Market: Drivers

Figure 5: Global Peripheral Interventional Devices Market: Challenges

Figure 6: Global Peripheral Interventional Devices Market: Trends

Figure 7: Global Peripheral Interventional Devices Market: Opportunity

Figure 8: Global Peripheral Interventional Devices Market: Restraint

Figure 9: Global Peripheral Interventional Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Peripheral Interventional Devices Market Value (USD Million) By Region

Figure 19: Global Peripheral Interventional Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Peripheral Interventional Devices Market Value (USD Million) By Region

Figure 27: Global Peripheral Interventional Devices Market Share (%) By: Regions (2032)

Figure 28: Global Peripheral Interventional Devices Market Volume (K) By Region

Figure 29: Global Peripheral Interventional Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Peripheral Interventional Devices Market Value (USD Million) By Region

Figure 37: Global Peripheral Interventional Devices Market Share (%) By: Regions (2032)

Figure 38: Global Peripheral Interventional Devices Market Volume (K) By Region

Figure 39: Global Peripheral Interventional Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Peripheral Interventional Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Peripheral Interventional Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Peripheral Interventional Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Peripheral Interventional Devices Market Value (USD Million) By Region

Table 14: Global Peripheral Interventional Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Peripheral Interventional Devices Market Volume (K) By Region

Table 31: Global Peripheral Interventional Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Peripheral Interventional Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Peripheral Interventional Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Peripheral Interventional Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Basic Information And Sales Area

Table 52: Abbott. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Boston Scientific Basic Information And Sales Area

Table 56: Boston Scientific. Products Portfolio

Table 57: Philips Basic Information And Sales Area

Table 58: Philips. Products Portfolio

Table 59: KDL Basic Information And Sales Area

Table 60: KDL. Products Portfolio

Table 61: Terumo Basic Information And Sales Area

Table 62: Terumo. Products Portfolio

Table 63: MicroPort Basic Information And Sales Area

Table 64: MicroPort. Products Portfolio

Table 65: Sinomed Basic Information And Sales Area

Table 66: Sinomed. Products Portfolio

Table 67: Lifetech Basic Information And Sales Area

Table 68: Lifetech. Products Portfolio

Table 69: Gore Basic Information And Sales Area

Table 70: Gore. Products Portfolio

Table 71: Cook Basic Information And Sales Area

Table 72: Cook. Products Portfolio

Table 73: Lepu Basic Information And Sales Area

Table 74: Lepu. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Peripheral Interventional Devices Market Value (USD Million) By Region

Table 84: Global Peripheral Interventional Devices Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Peripheral Interventional Devices Market Volume (K) By Region

Table 101: Global Peripheral Interventional Devices Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Peripheral Interventional Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Medtronic; Boston Scientific; Philips; KDL; Terumo; MicroPort; Sinomed; Lifetech; Gore; Cook; Lepu
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Peripheral Interventional Devices Segmentation Breakdown8 items

Application

Hospital

Specialist Clinic

Others

Types

Stent

Catheter

Thread

Regional Insights

Loading chart…

Competitive Landscape

Abbott: Regional expansion in APAC via OEM tie-ups and catheter innovation pipeline

Medtronic: Premium pricing strategy with focus on drug-coated balloon differentiation

Boston Scientific: Channel strength through hospital partnership programs and localized customization

Philips: Imaging-intervention synergy via partnerships with interventional radiology platforms

Terumo: Cost advantages via Japan-based vertical integration and lean manufacturing

Cook: Niche market leadership in venous access solutions with compliance-risk mitigation frameworks

Key Peripheral Interventional Devices Companies12 items

Abbott

Medtronic

Boston Scientific

Philips

KDL

Terumo

MicroPort

Sinomed

Lifetech

Gore

Cook

Lepu

Market Ecosystem

Raw material/component suppliers — provide polymers, metals, and coatings for device fabrication

OEMs/Manufacturers — design and produce peripheral interventional devices including stents and catheters

Technology licensors — offer proprietary imaging or drug-eluting platform solutions for device integration

Distributors/Channel partners — manage logistics and commercial access to hospital procurement networks

Hospitals/Clinics — deploy devices for peripheral artery disease and chronic wound management procedures

Regulators/Standards bodies — enforce CE marking, FDA clearance, and clinical trial protocols

Service providers — deliver device training, maintenance, and data analytics for procedural outcomes tracking

Recent Industry Insights

Analyst Overview

Table of Contents